Nektar Therapeutics grants director 4,000 options
The RSUs vest in full one year following September 23, 2026; the options vest monthly over a one-year period.
Rhea-AI Filing Summary
Nektar Therapeutics director Robert Chess received grants of 2,000 restricted stock units and 4,000 stock options on September 23, 2026. His direct common-stock holdings following the RSU award were 19,019 shares. Each RSU represents a contingent right to receive one common share upon vesting, and the award vests in full one year following September 23, 2026.
The options have a $57.66 exercise price, vest in substantially equal monthly installments over the one-year period beginning September 23, 2026, and expire September 22, 2034. The report also lists 140 shares held by his son; Chess disclaims beneficial ownership of those shares. No Rule 10b5-1 plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 6,000 shares
Grant/Award
5 txns
Insider
CHESS ROBERT
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F5 | 4,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1, F2, F3 | 2,000 | $0.00 | $0.00 |
| holding | Common Stock F3, F4 | -- | -- | -- |
| holding | Common Stock F3, F4 | -- | -- | -- |
| holding | Common stock F3, F4 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 4,000 contracts (Direct);
Common Stock — 19,019 shares (Direct);
Common Stock — 280 shares (Indirect, by daughter);
Common Stock — 140 shares (Indirect, by son)
Footnotes (5)
- F1. Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.
- F2. This RSU award vests in full, one year following September 23, 2026.
- F3. On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.
- F4. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.
- F5. This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.
Key Figures
Restricted stock units granted: 2,000 restricted stock units
Stock options granted: 4,000 stock options
Exercise price: $57.66 per share
+3 more
6 metrics
Restricted stock units granted
2,000 restricted stock units
Granted September 23, 2026
Stock options granted
4,000 stock options
Granted September 23, 2026
Exercise price
$57.66 per share
Stock options
Direct common-stock holdings
19,019 shares
Following the RSU award
Shares held by son
140 shares
Chess disclaims beneficial ownership
Option expiration
September 22, 2034
Stock options
Key Terms
restricted stock units ("RSUs"), vests in full, exercise price, beneficial ownership
4 terms
restricted stock units ("RSUs") financial
"grant of restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vests in full financial
"This RSU award vests in full"
exercise price financial
"conversion_or_exercise_price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
beneficial ownership regulatory
"disclaims beneficial ownership of these shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NKTR director Robert Chess receive?
On September 23, 2026, Robert Chess, a director of Nektar Therapeutics, received grants of 2,000 restricted stock units and 4,000 stock options. Each RSU represents a contingent right to receive one share of common stock upon vesting.
What are the terms of Robert Chess's NKTR stock options?
The 4,000 stock options have a $57.66 exercise price, vest in substantially equal monthly installments over the one-year period beginning September 23, 2026, and expire September 22, 2034. No Rule 10b5-1 plan is reported.
When do Robert Chess's NKTR restricted stock units vest?
The 2,000 restricted stock units vest in full one year following September 23, 2026. Each unit represents a contingent right to receive one share of Nektar Therapeutics common stock upon vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
